A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology.


Updates from The Motley Fool

Latest updates on Valeant Pharmaceuticals from Fool.com.


Stock Performance

VRX vs. S&P 500 | 2 Year Performance
View Interactive VRX Charts
Sponsored by

Key Data Points

Primary metrics and data points about Valeant Pharmaceuticals.
Current Price: $27.72
Prev Close: $26.85
Open: $26.56
Bid: $27.73
Ask: $27.79
Day's Range: $26.46 - $27.84
52wk Range: $18.55 - $217.07
Volume: 12,132,121
Avg Vol 25,964,888
Market Cap: $9.51B
P/E (ttm): -9.13
EPS (ttm): -$2.94
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Valeant Pharmaceuticals.
CAPS Rating 3 out of 5
 
518 Outperform
78 Underperform
CAPS All Stars
 
108 Outperform
27 Underperform

How do you think Valeant Pharmaceuticals will perform against the market?



You pick for Valeant Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Joseph C. Papa, CEO

0% Approve

Based on 1 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Valeant Pharmaceuticals.

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology.

  • Exchange: NYSE
  • Sector: Healthcare
  • Industry: Drug Makers